Micro Interventional Devices (MID) was founded in 2010 by Michael P. Whitman. The experienced management team, with proven track records in both early-stage and large company environments, gives Micro Interventional Devices, Inc. a significant competitive advantage.
MID is a medical device company that designs, manufactures and commercializes disruptive technologies for use in percutaneous and minimally invasive structural heart repair procedures.
Patients and Providers Win!
Our technology enables the transformation from open surgical procedures to transcatheter procedures.
The patient benefits include:
• Eliminating the need for open-heart surgery
• Eliminating the need for cardiopulomary bypass
• Reducing procedure time
• Reducing hospital stay and recovery time
While the applications of our technology are expansive, Micro Interventional Devices is setting its initial sights on three important unmet needs in structural heart disease: access and closure, mitral and tricuspid valve repair and mitral valve replacement. Permaseal™, MIA™ and Permavalve™ will drive the revolution in catheter-based solutions to structural heart disease.
MID's headquarters are located at 5 Caufield Place, Suite 102, Newtown, PA 18940. The Company is ISO 13485:2016 Certified and has an ISO Class 8 (100,000) manufacturing area.